HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums sales & earnings

This article was originally published in The Rose Sheet

Executive Summary

Fourth quarter U.S. sales, bolstered by the success of the Banana Republic personal care line, surged 141% to $19.8 mil. for the period (ended Dec. 31), firm reports Jan. 23. Company's European business posted strong growth, advancing 23% to $70.5 mil. on new items from Burberry, who had a "banner year" with Burberry London and increased brand sales 20%; Lanvin, which grew 20% on Eclat d'Arpège and Rumeur; and Paul Smith, where sales grew 22%. The jump helped drive Q4 sales up 34% to $90.3 mil. For 2006, sales "substantially" exceeded previous forecasts, climbing 16% to $321.1 mil. with net income of $17.2 mil. to $17.5 mil., firm says. Accordingly, Inter Parfums upped its 2007 projections to $365 mil. in sales with net income of $20.4 mil. Earlier this month, the firm outlined its upcoming launches, including the Gap personal care line (1"The Rose Sheet" Jan. 15, 2007, p. 9)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel